![ISPOR Europe 2024 – May 5-8. Register now.]({"type":"image" , "src" : "/sda/112342/JournalAd-ISPOR-2024-Leaderboard.jpg"})
Citations (65)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Vivek Rihal, Heena Khan, Amarjot Kaur & Thakur Gurjeet Singh. (2022) Vitamin D as therapeutic modulator in cerebrovascular diseases: a mechanistic perspectives. Critical Reviews in Food Science and Nutrition 0:0, pages 1-23.
Read now
Read now
Michael Wakeman. (2021) A Literature Review of the Potential Impact of Medication on Vitamin D Status. Risk Management and Healthcare Policy 14, pages 3357-3381.
Read now
Read now
Uwe Gröber, Joachim Schmidt & Klaus Kisters. (2020) Important drug-micronutrient interactions: A selection for clinical practice. Critical Reviews in Food Science and Nutrition 60:2, pages 257-275.
Read now
Read now
Vybhav Jetty, Charles J Glueck, Kevin Lee, Naila Goldenberg, Marloe Prince, Ashwin Kumar, Michael Goldenberg, Ishan Anand & Ping Wang. (2017) Eligibility for alirocumab or evolocumab treatment in 1090 hypercholesterolemic patients referred to a regional cholesterol treatment center with LDL cholesterol ≥70 mg/dL despite maximal-tolerated LDL-cholesterol-lowering therapy. Vascular Health and Risk Management 13, pages 247-253.
Read now
Read now
Vana Kolovou, Helen Bilianou & Genovefa Kolovou. (2016) Safe use of statins: focus on muscle toxicity. Clinical Lipidology 11:1, pages 16-22.
Read now
Read now
Helen I Keen, Janakan Krishnarajah, Timothy R Bates & Gerald F Watts. (2014) Statin myopathy: the fly in the ointment for the prevention of cardiovascular disease in the 21st century?. Expert Opinion on Drug Safety 13:9, pages 1227-1239.
Read now
Read now
Ineke J. Riphagen, Eveline van der Veer, Frits A.J. Muskiet & Mike J.L. DeJongste. (2012) Myopathy during statin therapy in the daily practice of an outpatient cardiology clinic: prevalence, predictors and relation with vitamin D. Current Medical Research and Opinion 28:7, pages 1247-1252.
Read now
Read now
Uwe Gröber & Klaus Kisters. (2012) Influence of drugs on vitamin D and calcium metabolism. Dermato-Endocrinology 4:2, pages 158-166.
Read now
Read now
Michael S. Kostapanos, Vasilios G. Athyros, Asterios Karagiannis & Dimitri P. Mikhailidis. (2012) Therapeutic options for statin-intolerant patients. Current Medical Research and Opinion 28:3, pages 345-349.
Read now
Read now
Claire Meek, Anthony S. Wierzbicki, Christina Jewkes, Patrick J. Twomey, Martin A. Crook, Alan Jones & Adie Viljoen. (2012) Daily and intermittent rosuvastatin 5 mg therapy in statin intolerant patients: an observational study. Current Medical Research and Opinion 28:3, pages 371-378.
Read now
Read now
Articles from other publishers (55)
Yumiko Tsushima & Betul Hatipoglu. (2023) Statin Intolerance: A Review and Update. Endocrine Practice 29:7, pages 566-571.
Crossref
Crossref
Giosiana Bosco, Francesco Di Giacomo Barbagallo, Salvatore Spampinato, Lorena Lanzafame, Antonino Di Pino, Salvatore Piro, Francesco Purrello & Roberto Scicali. (2023) Management of Statin Intolerant Patients in the Era of Novel Lipid Lowering Therapies: A Critical Approach in Clinical Practice. Journal of Clinical Medicine 12:6, pages 2444.
Crossref
Crossref
Ricardo Hernández Balboa, Luis Miguel Torres Morera, Sara Borrego Martín, Ramón Eizaga Rebollar & Rafael Garcia Hernandez. (2023) ¿Podría la Vitamina D ser una aliada en la Lucha contra el Dolor Crónico? ¿Qué dice la evidencia?. Multidisciplinary Pain Journal.
Crossref
Crossref
Mark A. Hlatky, Pedro Engel Gonzalez, JoAnn E. Manson, Julie E. Buring, I-Min Lee, Nancy R. Cook, Samia Mora, Vadim Bubes & Neil J. Stone. (2023) Statin-Associated Muscle Symptoms Among New Statin Users Randomly Assigned to Vitamin D or Placebo. JAMA Cardiology 8:1, pages 74.
Crossref
Crossref
Mark A. Tarnopolsky. (2022) Metabolic Myopathies. CONTINUUM: Lifelong Learning in Neurology 28:6, pages 1752-1777.
Crossref
Crossref
Claudio CaralloAlessandro Capozza & Agostino Gnasso. (2022) Effects of Vitamin D Supplementation in Patients with Statin-Associated Muscle Symptoms and Low Vitamin D Levels. Metabolic Syndrome and Related Disorders 20:10, pages 567-575.
Crossref
Crossref
Ateş Ş, Alkan Bozkaya T, İncir S, Çakıcı Ç, Yiğitbaşı T & Emekli N. (2022) Effects of vitamin D level and oxidant-antioxidant balance on postoperative morbidity in diabetic and non-diabetic patients undergoing off-pump bypass surgery. Advances in Tissue Engineering & Regenerative Medicine: Open Access 8:1, pages 11-16.
Crossref
Crossref
Mary Katherine Cheeley, Joseph J. Saseen, Anandita Agarwala, Sudha Ravilla, Nicole Ciffone, Terry A. Jacobson, Dave L. Dixon & Kevin C. Maki. (2022) NLA scientific statement on statin intolerance: a new definition and key considerations for ASCVD risk reduction in the statin intolerant patient. Journal of Clinical Lipidology 16:4, pages 361-375.
Crossref
Crossref
Chong Boon Teo, Pek Yan Tan, Ryan Yong Kiat Tay, Joan Khoo, Gerald F. Watts & Wann Jia Loh. (2022) Association Between Vitamin D Supplementation and Statin-Associated Muscle Symptoms: A Systematic Review. High Blood Pressure & Cardiovascular Prevention 29:4, pages 337-351.
Crossref
Crossref
Qingtao Hou, Caishuang Pang & Yuqin Chen. (2021) Association Between Vitamin D and Statin-Related Myopathy: A Meta-analysis. American Journal of Cardiovascular Drugs 22:2, pages 183-193.
Crossref
Crossref
Michele Malaguarnera. 2022. Features and Assessments of Pain, Anaesthesia, and Analgesia. Features and Assessments of Pain, Anaesthesia, and Analgesia
539
549
.
David J.A. Jenkins, J. David Spence, Edward L. Giovannucci, Young-in Kim, Robert G. Josse, Reinhold Vieth, Sandhya Sahye-Pudaruth, Melanie Paquette, Darshna Patel, Sonia Blanco Mejia, Effie Viguiliouk, Stephanie K. Nishi, Meaghan Kavanagh, Tom Tsirakis, Cyril W.C. Kendall, Sathish C. Pichika & John L. Sievenpiper. (2021) Supplemental Vitamins and Minerals for Cardiovascular Disease Prevention and Treatment. Journal of the American College of Cardiology 77:4, pages 423-436.
Crossref
Crossref
Allyson M. Schweitzer, Molly A. Gingrich, Thomas J. Hawke & Irena A. Rebalka. (2020) The impact of statins on physical activity and exercise capacity: an overview of the evidence, mechanisms, and recommendations. European Journal of Applied Physiology 120:6, pages 1205-1225.
Crossref
Crossref
Stefano Bellosta, Alberto Corsini & Nicola Ferri. 2020. Statin-Associated Muscle Symptoms. Statin-Associated Muscle Symptoms
51
61
.
Peter P. Toth. 2020. Statin-Associated Muscle Symptoms. Statin-Associated Muscle Symptoms
5
19
.
Pramod Reddy & Linda R. Edwards. (2019) Magnesium Supplementation in Vitamin D Deficiency. American Journal of Therapeutics 26:1, pages e124-e132.
Crossref
Crossref
Parth Shah. (2018) Economic Evaluation of the PCSK9 Inhibitors in Prevention of the Cardiovascular Diseases. Current Cardiology Reports 20:7.
Crossref
Crossref
Emily Mohn, Hua Kern, Edward Saltzman, Susan Mitmesser & Diane McKay. (2018) Evidence of Drug–Nutrient Interactions with Chronic Use of Commonly Prescribed Medications: An Update. Pharmaceutics 10:1, pages 36.
Crossref
Crossref
Joshua Choi, Amir M Khan, Michael Jarmin, Naila Goldenberg, Charles J Glueck & Ping Wang. (2017) Efficacy and safety of proprotein convertase subtilisin-kexin type 9 (PCSK9) inhibitors, alirocumab and evolocumab, a post-commercialization study. Lipids in Health and Disease 16:1.
Crossref
Crossref
Parth Shah, Charles J. Glueck, Naila Goldenberg, Sarah Min, Chris Mahida, Ilana Schlam, Matan Rothschild, Ali Huda & Ping Wang. (2017) Efficacy, safety, Low density lipoprotein cholesterol lowering, and calculated 10-year cardiovascular risk reduction of alirocumab and evolocumab in addition to maximal tolerated cholesterol lowering therapy: a post-commercialization study. Lipids in Health and Disease 16:1.
Crossref
Crossref
Wei-Han Cheng, Étienne Gaudette & Dana P. Goldman. (2017) PCSK9 Inhibitors Show Value for Patients and the US Health Care System. Value in Health 20:10, pages 1270-1278.
Crossref
Crossref
Maria Helde-Frankling & Linda Björkhem-Bergman. (2017) Vitamin D in Pain Management. International Journal of Molecular Sciences 18:10, pages 2170.
Crossref
Crossref
Jenny H. Kang, Quynh-Nhu Nguyen, Juleann Mutka & Quang A. Le. (2016) Rechallenging Statin Therapy in Veterans With Statin-Induced Myopathy Post Vitamin D Replenishment. Journal of Pharmacy Practice 30:5, pages 521-527.
Crossref
Crossref
Nikhil Sharma, Rachel Cooper, Diana Kuh & Imran Shah. (2017) Associations of statin use with motor performance and myalgia may be modified by 25-hydroxyvitamin D: findings from a British birth cohort. Scientific Reports 7:1.
Crossref
Crossref
Leonardo Calza, Eleonora Magistrelli, Vincenzo Colangeli, Marco Borderi, Ilaria Contadini, Isabella Bon, Maria Carla Re & Pierluigi Viale. (2017) Significant association between statin-associated myalgia and vitamin D deficiency among treated HIV-infected patients. AIDS 31:5, pages 681-688.
Crossref
Crossref
Charles J. Glueck, Kevin Lee, Marloe Prince, Alexander Milgrom, Frini Makadia & Ping Wang. (2017) Low serum vitamin D, statin associated muscle symptoms, vitamin D supplementation. Atherosclerosis 256, pages 125-127.
Crossref
Crossref
Parth Shah, Charles J. Glueck, Vybhav Jetty, Naila Goldenberg, Matan Rothschild, Rashid Riaz, Gregory Duhon & Ping Wang. (2016) Pharmacoeconomics of PCSK9 inhibitors in 103 hypercholesterolemic patients referred for diagnosis and treatment to a cholesterol treatment center. Lipids in Health and Disease 15:1.
Crossref
Crossref
Charles J. Glueck, Parth Shah, Naila Goldenberg, Marloe Prince, Kevin Lee, Vybhav Jetty, Ashwin Kumar, Michael Goldenberg & Ping Wang. (2016) Eligibility for PCSK9 treatment in 734 Hypercholesterolemic patients referred to a regional cholesterol treatment center with LDL cholesterol ≥70 mg/dl despite maximal tolerated cholesterol lowering therapy. Lipids in Health and Disease 15:1.
Crossref
Crossref
Krista D. Riche, Justin Arnall, Kristin Rieser, Honey E. East & Daniel M. Riche. (2016) Impact of vitamin D status on statin-induced myopathy. Journal of Clinical & Translational Endocrinology 6, pages 56-59.
Crossref
Crossref
Claudia Alejandra Pereda & Maria Betina Nishishinya. (2016) Is There Really a Relationship Between Serum Vitamin D (25OHD) Levels and the Musculoskeletal Pain Associated With Statin Intake? A Systematic Review. Reumatología Clínica (English Edition) 12:6, pages 331-335.
Crossref
Crossref
Claudia Alejandra Pereda & Maria Betina Nishishinya. (2016) ¿Existe relación entre los niveles séricos de vitamina D (25OHD) y el dolor musculoesquelético relacionado con la ingesta de estatinas? Revisión sistemática. Reumatología Clínica 12:6, pages 331-335.
Crossref
Crossref
Negar Maghsoodi & Anthony S. Wierzbicki. (2016) Statin myopathy. Current Opinion in Cardiology 31:4, pages 417-425.
Crossref
Crossref
Marie-Louise Ovesjö, Ilona Skilving, Peter Bergman, Anders Rane, Lena Ekström & Linda Björkhem-Bergman. (2016) Low Vitamin D Levels and Genetic Polymorphism in the Vitamin D Receptor are Associated with Increased Risk of Statin-Induced Myopathy. Basic & Clinical Pharmacology & Toxicology 118:3, pages 214-218.
Crossref
Crossref
G. Mpandzou, E. Aït Ben Haddou, W. Regragui, A. Benomar & M. Yahyaoui. (2016) Vitamin D deficiency and its role in neurological conditions: A review. Revue Neurologique 172:2, pages 109-122.
Crossref
Crossref
Ulrich Laufs, Hubert Scharnagl & Winfried März. (2015) Statin intolerance. Current Opinion in Lipidology 26:6, pages 492-501.
Crossref
Crossref
Ulrich Laufs, Hubert Scharnagl, Martin Halle, Eberhard Windler, Matthias Endres & Winfried März. (2015) Treatment Options for Statin-Associated Muscle Symptoms. Deutsches Ärzteblatt international.
Crossref
Crossref
Travis Y. Morioka, Alice J. Lee, Suzanne Bertisch & Catherine Buettner. (2015) Vitamin D status modifies the association between statin use and musculoskeletal pain: A population based study. Atherosclerosis 238:1, pages 77-82.
Crossref
Crossref
M. VRABLIK, L. ZLATOHLAVEK, T. STULC, V. ADAMKOVA, M. PRUSIKOVA, L. SCHWARZOVA, J. A. HUBACEK & R. CESKA. (2014) Statin-Associated Myopathy: From Genetic Predisposition to Clinical Management. Physiological Research, pages S327-S334.
Crossref
Crossref
Huifen Wang, Jeffrey B. Blumberg, C.-Y. Oliver Chen, Sang-Woon Choi, Michael P. Corcoran, Susan S. Harris, Paul F. Jacques, Aleksandra S. Kristo, Chao-Qiang Lai, Stefania Lamon-Fava, Nirupa R. Matthan, Diane L. McKay, Mohsen Meydani, Laurence D. Parnell, Max P. Prokopy, Tammy M. Scott & Alice H. Lichtenstein. (2014) Dietary modulators of statin efficacy in cardiovascular disease and cognition. Molecular Aspects of Medicine 38, pages 1-53.
Crossref
Crossref
Michael J. Wilkinson, Luke J. Laffin & Michael H. Davidson. (2014) Overcoming toxicity and side-effects of lipid-lowering therapies. Best Practice & Research Clinical Endocrinology & Metabolism 28:3, pages 439-452.
Crossref
Crossref
Peter J. Little, Alan Chait, Andrzej S. Januszewski, Alex Bobik, David O’Neal & Alicia J. Jenkins. 2014. Lipoproteins in Diabetes Mellitus. Lipoproteins in Diabetes Mellitus
435
453
.
G.B. John Mancini, A. Yashar Tashakkor, Steven Baker, Jean Bergeron, David Fitchett, Jiri Frohlich, Jacques Genest, Milan Gupta, Robert A. Hegele, Dominic S. Ng, Glen J. Pearson & Janet Pope. (2013) Diagnosis, Prevention, and Management of Statin Adverse Effects and Intolerance: Canadian Working Group Consensus Update. Canadian Journal of Cardiology 29:12, pages 1553-1568.
Crossref
Crossref
Jennifer A. Shannon, Samuel M. John, Harish S. Parihar, Shari N. Allen & Jenna J. Ferrara. (2013) A Clinical Review of Statin-Associated Myopathy. Journal of Pharmacy Technology 29:5, pages 219-230.
Crossref
Crossref
Brandon N. Conrad & Charles J. Glueck. (2013) Does low serum 25 OH vitamin D interact with very strenuous physical activity, facilitating development of rhabdomyolysis?. Medical Hypotheses 81:4, pages 551-552.
Crossref
Crossref
Thierry Thomas & Karine Briot. (2013) Effets osseux et musculaires de la vitamine D. La Presse Médicale 42:10, pages 1351-1357.
Crossref
Crossref
D. Rosenbaum, J. Dallongeville, P. Sabouret & E. Bruckert. (2013) Discontinuation of statin therapy due to muscular side effects: A survey in real life. Nutrition, Metabolism and Cardiovascular Diseases 23:9, pages 871-875.
Crossref
Crossref
Jamie Talan. (2013) NEWS FROM THE AAN ANNUAL MEETING. Neurology Today 13:9, pages 12-14.
Crossref
Crossref
Dimitrios Samaras, Nikolaos Samaras, Pierre-Olivier Lang, Laurence Genton, Emilia Frangos & Claude Pichard. (2013) Effects of widely used drugs on micronutrients: A story rarely told. Nutrition 29:4, pages 605-610.
Crossref
Crossref
Christian M. GirgisRoderick J. Clifton-BlighMark W. HamrickMichael F. HolickJenny E. Gunton. (2013) The Roles of Vitamin D in Skeletal Muscle: Form, Function, and Metabolism. Endocrine Reviews 34:1, pages 33-83.
Crossref
Crossref
Todd J. Anderson, Jean Grégoire, Robert A. Hegele, Patrick Couture, G.B. John Mancini, Ruth McPherson, Gordon A. Francis, Paul Poirier, David C. Lau, Steven Grover, Jacques GenestJrJr, André C. Carpentier, Robert Dufour, Milan Gupta, Richard Ward, Lawrence A. Leiter, Eva Lonn, Dominic S. Ng, Glen J. Pearson, Gillian M. Yates, James A. Stone & Ehud Ur. (2013) 2012 Update of the Canadian Cardiovascular Society Guidelines for the Diagnosis and Treatment of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult. Canadian Journal of Cardiology 29:2, pages 151-167.
Crossref
Crossref
Daniel Kurnik, Israel Hochman, Janet Vesterman‐Landes, Tali Kenig, Itzhak Katzir, Yosef Lomnicky, Hillel Halkin & Ronen Loebstein. (2012) Muscle pain and serum creatine kinase are not associated with low serum 25(OH) vitamin D levels in patients receiving statins. Clinical Endocrinology 77:1, pages 36-41.
Crossref
Crossref
Miao Hu, Bernard M.Y. Cheung & Brian Tomlinson. (2012) Safety of statins: an update. Therapeutic Advances in Drug Safety 3:3, pages 133-144.
Crossref
Crossref
Sivakumar Sathasivam. (2012) Statin induced myotoxicity. European Journal of Internal Medicine 23:4, pages 317-324.
Crossref
Crossref
Muhammad Haroon & Oliver FitzGerald. (2012) Vitamin D Deficiency: Subclinical and Clinical Consequences on Musculoskeletal Health. Current Rheumatology Reports 14:3, pages 286-293.
Crossref
Crossref
Niki Katsiki, Vasilios G. Athyros, Asterios Karagiannis & Dimitri P. Mikhailidis. (2012) Efficacy and tolerability of once-weekly rosuvastatin in patients with previous statin intolerance. Journal of Clinical Lipidology 6:1, pages 93.
Crossref
Crossref